Outcomes of Physicians with Substance Use Disorders in State Physician Health Programs: A Narrative Review.

Journal of Psychoactive Drugs
Matthew GoldenbergJesse Sanford

Abstract

The prevalence rate of addiction among physicians is similar to the general population, with approximately 10% to 12% of U.S.-based physicians developing substance use disorders (SUDs) during their lifetimes. To address this public health concern, physician health programs (PHPs) have been created to facilitate the early identification, evaluation, treatment, and monitoring of physicians. Although a number of published studies provide outcome information from PHPs, there has been no comprehensive review of the related literature. The objective of this narrative review is to summarize the treatment outcomes, including treatment types, rates of relapse, rates of contract completion or extension, as well as licensure and work status rates of a nationally representative physician cohort and related subpopulations from a single dataset. Based on the studies included in this review, our findings reveal that physicians who completed their PHP contracts have more favorable treatment outcomes than members of the general population who receive mainstream treatment. In addition, our review describes unique features of physician rehabilitation facilitated by PHPs. However, further prospective research is needed to ensure a standardized and...Continue Reading

References

Oct 1, 1991·Journal of Psychoactive Drugs·C Pelton, R M Ikeda
Apr 1, 1988·QRB. Quality Review Bulletin·J J Soter, S L Dilts
May 11, 1999·Journal of Addictive Diseases·R T Paris, D I Canavan
Mar 24, 2005·JAMA : the Journal of the American Medical Association·Karen B DominoLynn Hankes
Jan 24, 2007·Journal of Psychiatric Practice·John R KnightJohn A Fromson
Nov 6, 2008·BMJ : British Medical Journal·A Thomas McLellanRobert L DuPont
Jan 24, 2009·Journal of Substance Abuse Treatment·Robert L DuPontMark S Gold
Jun 2, 2009·Journal of Substance Abuse Treatment·Robert L DuPontGregory E Skipper
Dec 15, 2010·The Journal of Physician Assistant Education : the Official Journal of the Physician Assistant Education Association·Paul F JacquesWanda C Gonsalves
Nov 23, 2011·Archives of Surgery·Amanda BuhlRobert L Dupont
Apr 4, 2014·The Western Journal of Emergency Medicine·John S RoseGregory Skipper
Oct 2, 2014·Psychiatric Services : a Journal of the American Psychiatric Association·Peter M YellowleesRobert L DuPont
Mar 14, 2016·Journal of Substance Abuse Treatment·Lisa J MerloRobert L DuPont
Jan 10, 2017·Journal of Addiction Medicine·John S RoseRobert L DuPont
Jun 24, 2017·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Nancy M PetryKristyn Zajac
Oct 1, 2019·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu
Dec 10, 2019·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu· National Health Commission Of The People's Republic Of China

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.